Because the specific inhibition of GluN2A is reasonably effective in attenuating the symptoms of depression, it is equally effective in attenuating the impairment of synaptic plasticity, which also plays a significant role in the onset and development of depression. This evidence concerns the gene GRIN2A and major depressive disorder.